Medicare Enrolled
Dr. Eric Mininberg, M.D.
Hematology & Oncology · Atlanta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mininberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mininberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mininberg
Dr. Eric Mininberg is a hematology & oncology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mininberg performed 12,319 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mininberg received a total of $1,601 from 40 pharmaceutical and/or device companies across 80 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mininberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 16% volume in GA
$1,601 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,319
Medicare services
Top 16% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $44 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,652 | $0 | $0 |
| Iron infusion (Monoferric) | 1,400 | $16 | $65 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
942 | $8 | $27 |
| Anti-nausea injection (Aloxi/palonosetron) | 690 | $1 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
590 | $65 | $168 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
414 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
376 | $87 | $260 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
345 | $99 | $525 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
276 | $22 | $118 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
224 | $12 | $82 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
185 | $11 | $60 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
139 | $49 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
127 | $56 | $260 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
120 | $21 | $131 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
80 | $1 | $2 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
62 | $49 | $235 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
53 | $10 | $97 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
52 | $176 | $550 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
43 | $1 | $3 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
40 | $43 | $218 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 37 | $339 | $1,325 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
35 | $2 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $119 | $429 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
31 | $58 | $174 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
29 | $3 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $42 | $122 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $64 | $304 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
24 | $25 | $194 |
| New patient office visit, complex (60-74 min) | 24 | $156 | $544 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
24 | $1 | $6 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
19 | $74 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
18.5% high complexity
63.7% medium
17.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,601
Total received (2018-2024)
Avg $229/year across 7 years
Bottom 34% in GA for hematology & oncology
40
Companies
80
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$250
2023
$265
2022
$328
2021
$234
2020
$188
2019
$183
2018
$153
Payments by company (2024)
ABBVIE INC.
$157
Stemline Therapeutics Inc.
$29
Deciphera Pharmaceuticals Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$15
ARRAY BIOPHARMA INC
$15
Top 3 companies account for 81.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$221
Mentor Worldwide LLC
$143
Janssen Biotech, Inc.
$142
Seagen Inc.
$101
Pharmacyclics LLC, An AbbVie Company
$76
PFIZER INC.
$73
Pharmacyclics LLC, an AbbVie Company
$72
Novartis Pharmaceuticals Corporation
$59
Amgen Inc.
$52
Astellas Pharma US Inc
$44
Janssen Pharmaceuticals, Inc
$42
RECORDATI_RARE_DISEASES_INC.
$37
Epizyme, Inc.,
$32
Genentech USA, Inc.
$30
Stemline Therapeutics Inc.
$29
McKesson Specialty Care Distribution, LLC
$29
Bayer HealthCare Pharmaceuticals Inc.
$23
AbbVie Inc.
$23
CTI BioPharma Corp.
$23
E.R. Squibb & Sons, L.L.C.
$23
Rigel Pharmaceuticals, Inc.
$22
GENZYME CORPORATION
$20
Merck Sharp & Dohme LLC
$20
Merck Sharp & Dohme Corporation
$20
ADC Therapeutics America, Inc.
$19
Daiichi Sankyo Inc.
$18
Deciphera Pharmaceuticals Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Mylan Pharmaceuticals Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
EISAI INC.
$15
Lilly USA, LLC
$15
ARRAY BIOPHARMA INC
$15
Epizyme, Inc.
$15
AstraZeneca Pharmaceuticals LP
$13
Karyopharm Therapeutics Inc.
$12
Octapharma USA, Inc.
$12
Gilead Sciences, Inc.
$12
EMD Serono, Inc.
$11
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ARTOURA Breast Tissue Expander · Alecensa · Bavencio · CREON · CYMBALTA · DARZALEX · EPKINLY · Fulphila · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · Lenvima · MEKINIST · Neulasta · Nplate · Orserdu · PANZYGA · QINLOCK · Rezlidhia · SANDOSTATIN LAR · SYLVANT · Stivarga · TAZVERIK · TUKYSA · Tazverik · VENCLEXTA · Vonjo · XARELTO · XOSPATA · XPOVIO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
178
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
PIEDMONT HOSPITAL, INC
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mininberg is a mixed practice specialist, with above-average Medicare volume (top 16% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mininberg experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Mininberg performed 4,200 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mininberg receive payments from pharmaceutical companies?
Yes. Dr. Mininberg received a total of $1,601 from 40 companies across 80 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mininberg's costs compare to other hematology & oncology specialists in Atlanta?
Dr. Mininberg's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mininberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Atlanta
Browse hematology & oncology specialists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Mentor Worldwide LLC Payments to Doctors
See all physicians who received payments from Mentor Worldwide LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology